University of California, Davis
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Davis sits in the top decile of US sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count).
University of California, Davis: 657 sponsored US clinical trials, 123 recruiting.
University of California, Davis sponsors 657 registered US clinical trials on ClinicalTrials.gov, 123 of them currently recruiting, and 435 completed. 38 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 12 trials.
Top-decile sponsor footprint
University of California, Davis ranks in the top decile of sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
435 of 483 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
657 total, page 9 of 14
De Novo Lipogenesis of Sebaceous Glands in Acne
NCT02620813
Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer
NCT02437370
Smartphone Applications Youth With Early Psychosis in Community Outpatient Settings
NCT03286595
Pilot Study of Asynchronous and Synchronous Telepsychiatry for Skilled Nursing Facilities
NCT02537093
PASOS: Improving the Health of Immigrant Workers
NCT02480244
Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
NCT03204526
Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients
NCT02477462
Oxaliplatin in Treating Patients With Metastatic Breast Cancer
NCT02077998
HDL Lipidomic, Proteomic and Functional Changes in Women After Eating Eggs
NCT02445638
Correlation of Molecular Biomarkers With Biopsy Findings and Outcomes in Renal Transplant Recipients
NCT02463253
Visual Interpretation of Neonatal Growth Charts
NCT02403739
Supporting Baby Behavior Through Pediatric Offices
NCT02438878
Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides
NCT03526081
NSAIDS Versus Opioids in Acute SER II Ankle Fractures
NCT02373254
The Use of Microneedles With Topical Botulinum Toxin for Treatment of Palmar Hyperhidrosis
NCT03203174
Using Mobile Technology to Enhance Early Psychosis Treatment Delivery
NCT03303456
The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy
NCT02594644
Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer
NCT02240719
Topical Centella Asiatica and the Cosmetic Appearance of Stretch Marks
NCT02601105
GI Biorepository of Tissue and Bodily Fluids
NCT02486146
Novel Lung Functional Imaging for Personalized Radiotherapy
NCT02308709
Parent Mentors to Improve Adherence to Type I Diabetes Care Regimen in Adolescents
NCT03199716
Reducing Duration of Untreated Psychosis Through Rapid Identification and Engagement
NCT02841956
Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer
NCT02194049
N-of-1 Trials Using mHealth in Chronic Pain
NCT02116621
Sebum Collection and Skin Barrier Function Analysis
NCT03112876
Effect of Milk Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Children With Autism
NCT02086110
Stress and Sugar Synergy
NCT02143011
Impact of Individualized Radiotherapy Plan Review in Patients Receiving Adjuvant Radiotherapy for Breast Cancer
NCT02366806
A Controlled Trial of Patient Centered Telepsychiatry Interventions
NCT02084979
Commercial Lidocaine Patch as a Treatment for Ear-ringing
NCT02088866
Prospective Randomized Controlled Trial Comparing Water and Air Colonoscopy in a Community Based Setting
NCT01729416
Lisdexamfetamine's Effect In ADHD in the Brain and Cognition
NCT02170298
Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone
NCT02031718
The Effect of Microneedle Pretreatment on Topical Anesthesia
NCT02596750
Ultrasonographic Measurements of the Median Nerve Before and After Splinting for Carpal Tunnel Syndrome
NCT02038205
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
NCT02594969
Cancer Care Coordination for Chemotherapy Patients
NCT02238951
Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
NCT01963403
Accuracy of Pulse CO-Oximetry Technology in Characterizing Noninvasive SpHb
NCT01997502
The Lipid Profile of the Skin Surface in Acne
NCT02180425
One Lung Ventilation
NCT01997073
Dexmedetomidine and Renal Transplants
NCT02019121
Trendelenburg Study
NCT01979575
Oral Administration of Colostrum to Premature Babies: Impact on the Oral Microbiota
NCT02306980
Delayed Umbilical Cord Clamping - C-section Pilot
NCT02229162
Survey of Women's Choice of Delivery Before Consulting With Her Obstetrician
NCT02010671
INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung Cancer
NCT01911507
Effect of Alveolar Minute Ventilation on Respiratory Gas Heat Content
NCT01943227
A Pre-Cellular Therapy Observational Study in Early Huntington's Disease
NCT01937923
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 43 |
| Phase 3 | 10 |
| Phase 4 | 28 |
Therapeutic Areas
What is open in the University of California, Davis pipeline
123 recruiting of 657 indexed (19% open); 435 completed (66%).
Phase mix: 38 late (III/IV) vs 129 early (I/II) (early-phase heavy).
Top condition: Healthy (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Davis: open-pipeline peers nationwide
Peers matched on 657 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 657 trials (± recruiting share)
- Vanderbilt University Medical Center · 677 trials · 19% recruiting
- University of Rochester · 636 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
- Insulet Corporation · 19% recruiting · 16 trials
- Medical University of South Carolina · 19% recruiting · 755 trials
Related
What to do with this University of California, Davis page
657 registered trials is a research-attention snapshot, not an endorsement of University of California, Davis or any single study.
- 123 of University of California, Davis's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of California, Davis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Davis pipeline card: 657 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.